Assay Kits

Antibodies

Primary Antibodies

COMPLEMENT C5

INTERFERON GAMMA

Human

ELISA

WB

Mouse

Goat

Rabbit

Chicken

Biotin

IgG

Polyclonal

Indirect

Direct

Druggable Genome

Secreted Protein

Cytokine-cytokine receptor interaction

Pathways in cancer

Jak-STAT signaling pathway

Focal adhesion

MAPK signaling pathway

Melanoma

Glioma

Prostate cancer

Regulation of actin cytoskeleton

Gap junction

Bladder cancer

Hematopoietic cell lineage

Endometrial cancer

ErbB signaling pathway

Chemokine signaling pathway

Pancreatic cancer

Colorectal cancer

Endocytosis

Leukocyte transendothelial migration

Natural killer cell mediated cytotoxicity

Non-small cell lung cancer

p53 signaling pathway

Apoptosis

ECM-receptor interaction

Metabolic pathways

Pyruvate metabolism

Renal cell carcinoma

TGF-beta signaling pathway

mTOR signaling pathway

Acute myeloid leukemia

Adherens junction

Adipocytokine signaling pathway

Asthma

Axon guidance

Calcium signaling pathway

Cell adhesion molecules (CAMs)

Cell cycle

Chronic myeloid leukemia

Citrate cycle (TCA cycle)

Complement and coagulation cascades

Dilated cardiomyopathy

Dorso-ventral axis formation

Epithelial cell signaling in Helicobacter pylori infection

Glyoxylate and dicarboxylate metabolism

GnRH signaling pathway

Hypertrophic cardiomyopathy (HCM)

Long-term depression

Melanogenesis

Neuroactive ligand-receptor interaction

Nicotinate and nicotinamide metabolism

Notch signaling pathway

Oocyte meiosis

Progesterone-mediated oocyte maturation

Small cell lung cancer

Systemic lupus erythematosus

Thyroid cancer

Wnt signaling pathway

Allograft rejection

Alzheimer's disease

Amyotrophic lateral sclerosis (ALS)

Cytosolic DNA-sensing pathway

Glycolysis / Gluconeogenesis

Graft-versus-host disease

Nitrogen metabolism

Porphyrin and chlorophyll metabolism

Prion diseases

Propanoate metabolism

Proteasome

RIG-I-like receptor signaling pathway

Regulation of autophagy

Riboflavin metabolism

T cell receptor signaling pathway

Toll-like receptor signaling pathway

Type I diabetes mellitus

2